Category: Disclosures

[Disclosure] Samsung Biologics (207940) – Result of Action Such as Prosecution Referral for Violation of Accounting Standards / 2025-07-17

July 17, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed that the Supreme Court (court of third instance) dismissed the prosecution’s appeal regarding alleged violations of accounting standards, rendering a not-guilty verdict. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Supreme Court Appeal Dismissal and…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – (Correction) Result of Action Such as Prosecution Referral for Violation of Accounting Standards / 2025-07-17

July 17, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a corrected disclosure confirming that the Supreme Court dismissed the prosecution’s appeal regarding alleged violations of accounting standards, finalizing a not-guilty verdict, and updated the filing upon receipt of the official written judgment. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] Hana Micron (067310) – Results of Extraordinary General Meeting of Shareholders / 2025-07-16

July 16, 2025August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary At Hana Micron’s extraordinary general meeting of shareholders, the proposals for approving the corporate split plan and appointing directors and an auditor were approved as originally submitted, while the proposal to amend the Articles of Incorporation was rejected. 📊 Key Disclosure Content & Financial Figures Summary…

Semiconductors, Disclosures

[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2025-07-16

July 16, 2025August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems will hold an Investor Relations (IR) event via conference call and webcast on July 29, 2025, at 16:00 KST for shareholders, analysts, institutional investors, and media to present its Q2 2025 earnings and conduct a Q&A session. 📊 [Key Disclosure Details & Financial Highlights]…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Additional Listing (Paid-in Capital Increase via Rights Issue) / 2025-07-16

July 16, 2025August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace disclosed the additional listing of 4,267,200 common shares issued through a rights issue to existing shareholders, scheduled for listing on July 21, 2025, at an issue price of KRW 684,000 per share. 📊 [Key Disclosure Contents & Summary of Figures] [Additional Listing Details] [Mandatory…

Disclosures, Defense

[Disclosure] Hanwha Ocean (042660) – Pre-announcement of Financial Results / 2025-07-15

July 15, 2025August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing pre-announces that Hanwha Ocean plans to disclose its provisional financial results for Q2 2025 on July 29, 2025. 📊 Key Filing Details & Key Figures Summary 1. Pre-announcement Overview 2. Other Key Reference Information 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Provisional…

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Presentation / 2025-07-15

July 15, 2025August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing announces that Hanwha Ocean will hold an Investor Relations (IR) presentation via conference call and webcasting on July 29, 2025, at 14:00 to present its Q2 2025 financial results to securities analysts and institutional investors. 📊 Key Filing Details & Key Figures Summary 1….

Disclosures, Shipbuilding

[Disclosure] Samsung Biologics (207940) – Setting of Record Date or Period for Closure of Shareholder Register / 2025-07-14

July 14, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed that it set July 29, 2025, as the record date to determine shareholders entitled to exercise voting rights at the upcoming Extraordinary General Meeting of Shareholders. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying Record…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Rulings on Lawsuit (Correction) / 2025-07-11

July 11, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion submitted a corrected disclosure after receiving the official 1st instance court judgment regarding the COVID-19 diagnostic kit lawsuit with Humasis, detailing the specific order and noting a separate favorable ruling of approx. KRW 3.89B in Celltrion’s counter-suit. 📊 [Key Disclosure Details & Financial Summary] 📝…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – Advance Notice of Financial Results Disclosure / 2025-07-11

July 11, 2025August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace disclosed an advance notice indicating that it plans to release its provisional Q2 2025 financial results on July 31, 2025. 📊 [Key Disclosure Contents & Summary of Figures] [Earnings Announcement Schedule] [Other Key Considerations] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Q2…

Disclosures, Defense